| Literature DB >> 34207509 |
Lucia Bonadonna1, Rossella Briancesco1, Anna Maria Coccia1, Pierluigi Meloni1, Giuseppina La Rosa1, Umberto Moscato2,3.
Abstract
There is increasing evidence that indoor air quality and contaminated surfaces provide an important potential source for transmission of pathogens in hospitals. Airborne hospital microorganisms are apparently harmless to healthy people. Nevertheless, healthcare settings are characterized by different environmental critical conditions and high infective risk, mainly due to the compromised immunologic conditions of the patients that make them more vulnerable to infections. Thus, spread, survival and persistence of microbial communities are important factors in hospital environments affecting health of inpatients as well as of medical and nursing staff. In this paper, airborne and aerosolized microorganisms and their presence in hospital environments are taken into consideration, and the factors that collectively contribute to defining the infection risk in these facilities are illustrated.Entities:
Keywords: healthcare facilities; indoor air; microbial contamination; surface contamination
Mesh:
Year: 2021 PMID: 34207509 PMCID: PMC8296088 DOI: 10.3390/ijerph18126226
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Sources, conditions and risk factors of contamination of the HVAC system: simplified scheme [47].
Figure 2Matrix of the risk level to which the patient is exposed in air conditioned hospital environments [47].
Pathogenic bacteria and fungi detected in fomites and hospital environments, their survival and references.
| Bacteria | Duration of Survival on Inanimate Surfaces (Range) | References |
|---|---|---|
| 2 days–>4 months | [ | |
|
| 3–5 days | [ |
|
| >1 week | [ |
|
| 15 min–7 h | [ |
|
| 30 min–≤30 h | [ |
|
| 15 days to months | [ |
| 5 months | [ | |
|
| 7 days–6 months | [ |
|
| 1–8 days | [ |
| 5 day–3 months | [ | |
| <1 h–28 days | [ | |
|
| 12 days | [ |
|
| ≤90 min | [ |
|
| 1 h–6 weeks | [ |
|
| at least 24 h | [ |
|
| 10–120 day | [ |
|
| >24 h | [ |
|
| 72 h | [ |
|
| 4 h–26 days | [ |
|
| 1–2 days | [ |
|
| 5 h–33 days | [ |
| 1–>24 h | [ | |
| 1–48 h | [ | |
| 5 h–12 weeks | [ | |
|
| 6 h–4 weeks | [ |
| at least 30 days | [ | |
|
| <1 h–11 days | [ |
| 1.5–4 h | [ | |
| 6 h–12 days | [ | |
|
| 2–7 days | [ |
|
| 1 day up 30 months | [ |
|
| 3 days–6.5 months | [ |
|
| up to 5 days | [ |
| Yeasts and Molds | ||
|
| 1–120 days | [ |
| 3–14 days | [ | |
|
| 30 days | [ |
| 1 year | [ | |
|
| 2–30 days | [ |
|
| 1–30 days | [ |
|
| 1–30 days | [ |
| 48 h–>30 days | [ | |
| 16–>30 days | [ | |
| <1–11 days | [ | |
|
| 6–120 h | [ |
MRD: multi resistant drugs.
Viruses detected in fomites and hospital environments, their survival and references.
| Viruses | Duration of Survival on Inanimate Surfaces (Range) | References |
|---|---|---|
| Adenovirus | 1 h–>12 weeks | [ |
| Astrovirus | 7–90 days | [ |
|
| <5 min–>168 days | [ |
| Coronavirus (SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV -229E, HCoV -OC43, HCoV -NL63) | 30 min–>8 days | [ |
| Coxsackie virus | 2–5 weeks | [ |
| Cytomegalovirus | 1 h–4 h | [ |
| Echovirus | 48 h–7 days | [ |
| Filoviruses | 2 days–>32 days | [ |
| Hepatitis A Virus | 2 h–>60 days | [ |
| Hepatitis B Virus | >14 days | [ |
| Hepatitis C Virus | 5 days–6 weeks | [ |
| Human Immunodeficiency Virus | >5 days | [ |
| Herpes Simplex Virus, Type 1 and 2 | 4.5 h–>8 weeks | [ |
| Human Metapneumovirus (HMPV) | 2–8 h | [ |
| Influenza Virus | 1–2 days | [ |
| Parainfluenza Virus | <0.5 h–>8 h | [ |
| Feline Norovirus and Calicivirus | 8 h–7 days | [ |
|
| >7 days | [ |
| Papovavirus | 8 days | [ |
| Parvovirus | >1 year | [ |
| Poliovirus Type 1 | 4 h– >60 days | [ |
| Poliovirus Type 2 | 1 day–8 weeks | [ |
|
| <1 day–56 days | [ |
| Pseudorabies Virus | >/= 7 days | [ |
| Respiratory Syncytial Virus | 0.5 h–6 months | [ |
| Rhinovirus | 2 h–7 days | [ |
| Rotavirus | 1 h–>60 days | [ |
| Vaccinia Virus | 3–>20 weeks | [ |